Item Type | Name |
Concept
|
Cytokines
|
Concept
|
Body Mass Index
|
Concept
|
Saliva
|
Concept
|
Primary Health Care
|
Concept
|
Specimen Handling
|
Concept
|
Age Factors
|
Concept
|
Disease Models, Animal
|
Concept
|
Interleukin-10
|
Concept
|
Mycobacterium tuberculosis
|
Concept
|
Heat-Shock Proteins
|
Concept
|
Interferon-gamma
|
Concept
|
Latent Tuberculosis
|
Concept
|
Incidence
|
Concept
|
Filtration
|
Concept
|
Recurrence
|
Concept
|
Geography
|
Concept
|
Tuberculin Test
|
Concept
|
Ethambutol
|
Concept
|
Diabetes Complications
|
Concept
|
Blood
|
Concept
|
Mycobacterium Infections, Nontuberculous
|
Concept
|
Genes, Dominant
|
Concept
|
Genomics
|
Concept
|
Cell Wall
|
Concept
|
HIV-1
|
Concept
|
Prostatitis
|
Concept
|
China
|
Concept
|
Genetic Testing
|
Concept
|
Confidence Intervals
|
Concept
|
Antibiotics, Antitubercular
|
Concept
|
Interviews as Topic
|
Concept
|
Nontuberculous Mycobacteria
|
Concept
|
Disease Susceptibility
|
Concept
|
Algorithms
|
Concept
|
Cohort Studies
|
Concept
|
Uganda
|
Concept
|
CD4 Lymphocyte Count
|
Concept
|
BCG Vaccine
|
Concept
|
Rifampin
|
Concept
|
Mycobacterium
|
Concept
|
Vietnam
|
Concept
|
Mortality
|
Concept
|
Mycobacterium avium-intracellulare Infection
|
Concept
|
Culture Media
|
Concept
|
Diabetes Mellitus
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Observer Variation
|
Concept
|
Family Characteristics
|
Concept
|
Asia
|
Concept
|
Area Under Curve
|
Concept
|
Clinical Protocols
|
Concept
|
Reagent Kits, Diagnostic
|
Concept
|
Cell Line, Transformed
|
Concept
|
Nocardia
|
Concept
|
Republic of Korea
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
HIV Infections
|
Concept
|
Anti-HIV Agents
|
Concept
|
Retrospective Studies
|
Concept
|
T-Lymphocytes
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Serologic Tests
|
Concept
|
Drug Resistance, Multiple, Bacterial
|
Concept
|
Decision Support Techniques
|
Concept
|
Cross Infection
|
Concept
|
Urinalysis
|
Concept
|
Tuberculosis
|
Concept
|
Survival Rate
|
Concept
|
Cerebellum
|
Concept
|
Body Fluids
|
Concept
|
Urine
|
Concept
|
Tuberculosis, Multidrug-Resistant
|
Concept
|
DNA, Bacterial
|
Concept
|
Drug Monitoring
|
Concept
|
Tuberculosis, Pulmonary
|
Concept
|
Hospitals
|
Concept
|
Immunoglobulin A
|
Concept
|
Longitudinal Studies
|
Concept
|
Bacteriological Techniques
|
Concept
|
Communicable Disease Control
|
Concept
|
Bacterial Typing Techniques
|
Concept
|
India
|
Concept
|
Ambulatory Care Facilities
|
Concept
|
Health Care Surveys
|
Concept
|
Hospitals, Public
|
Concept
|
Health Care Costs
|
Concept
|
Bacteremia
|
Concept
|
Cluster Analysis
|
Concept
|
Gold
|
Concept
|
Cell Culture Techniques
|
Concept
|
Molecular Diagnostic Techniques
|
Concept
|
Lymphocyte Activation
|
Concept
|
Clinical Competence
|
Concept
|
Cost-Benefit Analysis
|
Concept
|
Mycobacterium bovis
|
Concept
|
Genetic Carrier Screening
|
Concept
|
Leukocytes, Mononuclear
|
Concept
|
Medical Audit
|
Concept
|
Extensively Drug-Resistant Tuberculosis
|
Concept
|
Mass Screening
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Microbial Sensitivity Tests
|
Concept
|
Sputum
|
Concept
|
Clinical Laboratory Techniques
|
Concept
|
Prospective Studies
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Benzoxazines
|
Concept
|
Contact Tracing
|
Concept
|
Antitubercular Agents
|
Concept
|
Nocardia Infections
|
Concept
|
Drug Resistance, Bacterial
|
Concept
|
Bacterial Infections
|
Concept
|
Cell Line
|
Concept
|
DNA-Directed RNA Polymerases
|
Concept
|
South Africa
|
Concept
|
Carboxylic Ester Hydrolases
|
Concept
|
Cytodiagnosis
|
Concept
|
Risk Factors
|
Concept
|
Directly Observed Therapy
|
Concept
|
Emigration and Immigration
|
Concept
|
Genes, Recessive
|
Concept
|
Follow-Up Studies
|
Concept
|
Mycobacterium avium Complex
|
Concept
|
Rifamycins
|
Concept
|
HIV
|
Concept
|
Immunohistochemistry
|
Concept
|
Comorbidity
|
Concept
|
Tuberculosis Vaccines
|
Concept
|
Molecular Sequence Data
|
Concept
|
Cell Count
|
Concept
|
Infection Control
|
Academic Article
|
Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.
|
Academic Article
|
Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults.
|
Academic Article
|
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
|
Academic Article
|
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis.
|
Academic Article
|
Mycobacterium tuberculosis in solid organ transplant recipients.
|
Academic Article
|
Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative.
|
Academic Article
|
Diagnosis of HIV-associated tuberculosis.
|
Academic Article
|
A Case of Malaria Predisposing to Salmonella Bacteremia in a Returning Traveler from Nigeria.
|
Academic Article
|
Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.
|
Academic Article
|
The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
|
Academic Article
|
Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
|
Academic Article
|
From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.
|
Academic Article
|
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
|
Academic Article
|
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
|
Academic Article
|
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
|
Academic Article
|
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
|
Academic Article
|
T-SPOT.TB responses during treatment of pulmonary tuberculosis.
|
Academic Article
|
Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.
|
Academic Article
|
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
|
Academic Article
|
Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
|
Academic Article
|
Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.
|
Academic Article
|
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.
|
Academic Article
|
QuantiFERON-TB Gold In-Tube for the detection of Mycobacterium tuberculosis infection in children with household tuberculosis contact.
|
Academic Article
|
Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.
|
Academic Article
|
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
|
Academic Article
|
Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability.
|
Academic Article
|
Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis.
|
Academic Article
|
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
|
Academic Article
|
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
|
Academic Article
|
Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial.
|
Academic Article
|
Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.
|
Academic Article
|
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
|
Academic Article
|
Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
|
Academic Article
|
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
|
Academic Article
|
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
|
Academic Article
|
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
|
Academic Article
|
Reply to Alffenaar et al.
|
Academic Article
|
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.
|
Academic Article
|
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
|
Academic Article
|
Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial.
|
Academic Article
|
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.
|
Academic Article
|
Field evaluation of a rapid immunochromatographic test for tuberculosis.
|
Academic Article
|
Nocardia veterana as a pathogen in North American patients.
|
Academic Article
|
Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens.
|
Academic Article
|
The rapid development of fluoroquinolone resistance in M. tuberculosis.
|
Academic Article
|
Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.
|
Academic Article
|
Mycobacterium tuberculosis cell envelope lipids and the host immune response.
|
Academic Article
|
Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection.
|
Academic Article
|
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
|
Academic Article
|
Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care.
|
Academic Article
|
Lymphadenitis in an 18-month-old traveler to Mexico.
|
Academic Article
|
Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens.
|
Academic Article
|
Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study.
|
Academic Article
|
Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
|
Academic Article
|
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
|
Academic Article
|
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
|
Academic Article
|
Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis.
|
Academic Article
|
Nontuberculous mycobacteria in solid organ transplant recipients.
|
Academic Article
|
New diagnostic tests for tuberculosis: bench, bedside, and beyond.
|
Academic Article
|
Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study.
|
Academic Article
|
A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa.
|
Academic Article
|
Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.
|
Academic Article
|
Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey.
|
Academic Article
|
Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic.
|
Academic Article
|
Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.
|
Academic Article
|
The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States.
|
Academic Article
|
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
|
Academic Article
|
QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.
|
Academic Article
|
Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa.
|
Academic Article
|
Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil.
|
Academic Article
|
Interferon-? release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
|
Academic Article
|
Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals.
|
Academic Article
|
Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.
|
Academic Article
|
Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis.
|
Academic Article
|
Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda.
|
Academic Article
|
Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
|
Academic Article
|
Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda.
|
Academic Article
|
Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation.
|
Academic Article
|
Advances in the diagnosis of tuberculosis: current status and future prospects.
|
Academic Article
|
Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South Africa.
|
Academic Article
|
Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis.
|
Academic Article
|
Comparing TSPOT assay results between an Elispot reader and manual counts.
|
Academic Article
|
Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.
|
Academic Article
|
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
|
Academic Article
|
Molecular Drug-Susceptibility Test for Tuberculosis.
|
Academic Article
|
Serologic Responses in Childhood Pulmonary Tuberculosis.
|
Academic Article
|
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
|
Academic Article
|
Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study.
|
Academic Article
|
A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.
|
Academic Article
|
Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
|
Academic Article
|
Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
|
Academic Article
|
Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.
|
Academic Article
|
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.
|
Academic Article
|
Predictive value of TNF-a, IFN-?, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada.
|
Concept
|
Interferon-gamma Release Tests
|
Concept
|
Dried Blood Spot Testing
|
Concept
|
Coinfection
|
Concept
|
Asymptomatic Infections
|
Concept
|
Enzyme-Linked Immunospot Assay
|
Concept
|
Pharmacogenomic Testing
|
Concept
|
Equivalence Trials as Topic
|
Academic Article
|
Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed.
|
Academic Article
|
Isolated intracranial infection with Mycobacterium avium complex.
|
Academic Article
|
A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states.
|
Academic Article
|
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies.
|
Academic Article
|
Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis.
|
Academic Article
|
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.
|
Academic Article
|
Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study.
|
Academic Article
|
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
|
Academic Article
|
Latent Tuberculosis Infection. Reply.
|
Academic Article
|
Latent Tuberculosis Infection.
|
Academic Article
|
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
|
Academic Article
|
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.
|
Academic Article
|
Four-Month Rifapentine Regimens for Tuberculosis. Reply.
|
Academic Article
|
A Case of Peritoneal Tuberculosis Mimicking Ovarian Cancer in a Young Female.
|
Academic Article
|
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.
|
Academic Article
|
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.
|
Academic Article
|
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
|
Academic Article
|
Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infection.
|
Academic Article
|
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase TB Trials.
|